[1]Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol,2021,18(3):151-166.
[2]Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues[J]. Mol Aspects Med,2019,65:37-55.
[3]Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: mechanistic concepts and therapeutic perspectives[J]. Cells,2020,9(4):875.
[4]Dai KQ, Ding Y, Fan JY, et al. Advance in the study of bone marrow mesenchymal stem cell differentiation into hepatocyte in vitro[J]. Acta Anatomica Sinica, 2015,46(5):704-709. (in Chinese)
代克强, 丁一, 樊晋宇, 等. 体外诱导骨髓间充质干细胞成肝(样)细胞的研究进展[J]. 解剖学报,2015,46(5):704-709.
[5]Steinhart Z, Angers S. Wnt signaling in development and tissue homeostasis[J]. Development,2018,145(11):dev146589.
[6]Perugorria MJ, Olaizola P, Labiano I, et al. Wnt-beta-catenin signaling in liver development, health and disease[J]. Nat Rev Gastroenterol Hepatol,2019,16(2):121-136.
[7]Alwa hsh SM, Rashidi H, Hay DC. Liver cell therapy: is this the end of the beginning [J]?. Cell Mol Life Sci,2018,75(8):1307-1324.
[8]Koike H, Taniguchi H. Characteristics of hepatic stem/progenitor cells in the fetal and adult liver[J]. J Hepatobiliary Pancreat Sci,2012,19(6):587-593.
[9]Suthon S, Perkins RS, Bryja V, et al. Wnt5b in physiology and disease[J]. Front Cell Dev Biol,2021,9:724948.
[10]Bi Y, He Y, Huang JY, et al. Functional characteristics of reversibly immortalized hepatic progenitor cells derived from mouse embryonic liver[J].Cell Physiol Biochem,2014,34(4):1318-1338.
[11]Sun M, Kisseleva T. Reversibility of liver fibrosis[J]. Clin Res Hepatol Gastroenterol,2015,39(1):S60-S63.
[12]Duan XX, Wang Y, He JJ, et al. Progress of the application of stem cell therapy for end-stage liver disease[J]. Journal of Central South University(Medical Science), 2017,42(4):457-462. (in Chinese)
段星祥, 王洋, 贺菁菁, 等. 干细胞治疗终末期肝病的进展[J]. 中南大学学报(医学版),2017,42(4):457-462.
[13]Li Q, Zhou X, Shi Y, et al. In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury[J]. PLoS One,2013,8(4):e62363.
[14]Miao C, Yang Y, He X, et al. Wnt signaling in liver fibrosis: Progress, challenges and potential directions[J]. Biochimie, 2013,95(12):2326-2335.
[15]Mu YP, Zhang X, Xu Y, et al. Notch signaling pathway participates in the differentiation of hepatic progenitor cells into bile duct epithelial cells and progression of hepatic fibrosis in cholestatic liver fibrosis rat[J]. Chinese Journal of Pathology,2017,46(6):400-405. (in Chinese)
慕永平,张笑,徐莹,等. Notch信号通路参与大鼠胆汁性肝纤维化肝祖细胞向胆管上皮细胞分化以及肝纤维化进展[J]. 中华病理学杂志,2017,46(6):400-405.
[16]Haworth K, Samuel L, Black S, et al. Liver specification in the absence of cardiac differentiation revealed by differential sensitivity to Wnt/β catenin pathway activation[J]. Front Physiol,2019,10:155.
[17]Aimaiti Y, Jin X, Shao Y, et al. Hepatic stellate cells regulate hepatic progenitor cells differentiation via the TGF-β1/Jagged1 signaling axis[J]. J Cell Physiol,2019,234(6):9283-9296.
[18]Luo J, Chen J, Deng Z, et al. Wnt signaling and human diseases: what are the therapeutic implications[J]? Lab Invest,2007,87(2):97-103.
[19]Sarvandi SS, Joghataei MT, Parivar K, et al. In vitro differentiation of rat mesenchymal stem cells to hepatocyte lineage[J]. Iran J Basic Med Sci,2015,18(1):89-97.
[20]Wang J, Kang Q, Luo Q, et al. Effects of pathologic microenvironmental cytokines derived from cholestatic cirrhosis on liver stem cell differentiation[J]. Chinese Journal of Cell Biology, 2018,40(4):490-498. (in Chinese)
王健,康权,罗庆,等. 胆汁淤积性肝硬化来源的微环境因子对肝脏干细胞分化的影响[J]. 中国细胞生物学学报,2018,40(4):490-498.
|